Beurs gesloten -
OTC Markets
21:51:15 19-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
0,000001
USD
|
-99,00%
|
|
0,00%
|
0,00%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
407
|
363
|
257,9
|
89,95
|
111,1
|
Bedrijfswaarde
1 |
605
|
540,4
|
366,3
|
97,15
|
124
|
K/w-verhouding
|
-3,2
x
|
-1,35
x
|
-3,14
x
|
-1,12
x
|
-1,95
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,54
x
|
1,51
x
|
1,45
x
|
5,14
x
|
2,23
x
|
Bedrijfswaarde/omzet
|
2,29
x
|
2,25
x
|
2,06
x
|
5,55
x
|
2,49
x
|
Bedrijfswaarde/EBITDA
|
7,82
x
|
9,99
x
|
17,4
x
|
-1,41
x
|
-3,13
x
|
Bedrijfswaarde/FCF
|
13,8
x
|
14,9
x
|
24,3
x
|
-4,15
x
|
-9,78
x
|
FCF Yield
|
7,25%
|
6,71%
|
4,12%
|
-24,1%
|
-10,2%
|
Price to Book
|
1,05
x
|
3,16
x
|
2,75
x
|
1,17
x
|
2,17
x
|
Aantal aandelen (in duizenden)
|
52.519
|
51.926
|
62.586
|
83.290
|
99.154
|
Referentieprijs
2 |
7,750
|
6,990
|
4,120
|
1,080
|
1,120
|
Datum van publicatie
|
28/03/19
|
19/03/20
|
30/03/21
|
30/03/22
|
20/03/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
245,7
|
263,7
|
240
|
177,9
|
17,5
|
49,72
|
EBITDA
1 |
66,28
|
77,36
|
54,1
|
21,02
|
-69,14
|
-39,6
|
Bedrijfsresultaat (EBIT)
1 |
30,68
|
5,683
|
3,052
|
1,747
|
-77,31
|
-39,98
|
Operationele Marge
|
12,49%
|
2,16%
|
1,27%
|
0,98%
|
-441,75%
|
-80,41%
|
Resultaat voor belastingen (EBT)
1 |
-85,64
|
-118,7
|
-298
|
-84,29
|
-82,53
|
-51,71
|
Nettowinst (verlies)
1 |
-45,15
|
-109,4
|
-270,9
|
-79,59
|
-64,92
|
-51,69
|
Nettomarge
|
-18,37%
|
-41,48%
|
-112,86%
|
-44,74%
|
-370,95%
|
-103,96%
|
WPA
2 |
-45,14
|
-2,420
|
-5,173
|
-1,312
|
-0,9639
|
-0,5757
|
Free Cash Flow
1 |
32,75
|
43,86
|
36,25
|
15,09
|
-23,41
|
-12,68
|
FCF-marge
|
13,33%
|
16,63%
|
15,1%
|
8,48%
|
-133,74%
|
-25,5%
|
Kasstroomconversie (ebitda)
|
49,42%
|
56,7%
|
67,01%
|
71,79%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
9/05/18
|
28/03/19
|
19/03/20
|
30/03/21
|
30/03/22
|
20/03/23
|
Fiscaal tijdperk: december |
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
---|
Omzet
1 |
23,88
|
34,8
|
2,196
|
2,86
|
21,44
|
8,448
|
10,02
|
9,807
|
8,832
|
8,258
|
EBITDA
|
-5,777
|
-8,35
|
-20,32
|
-15,23
|
-18,9
|
-11,75
|
-10,91
|
-9,32
|
-8,655
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-6,206
|
-12,3
|
-25,17
|
-23,06
|
-5,396
|
-15,12
|
-13,92
|
-24,55
|
-10,29
|
-8,121
|
Operationele Marge
|
-25,99%
|
-35,34%
|
-1.146,08%
|
-806,22%
|
-25,16%
|
-179,02%
|
-138,91%
|
-250,31%
|
-116,52%
|
-98,34%
|
Resultaat voor belastingen (EBT)
1 |
-9,079
|
-17,42
|
-26,02
|
-19,78
|
-6,896
|
-11,83
|
-14,38
|
-18,6
|
-11,55
|
-24
|
Nettowinst (verlies)
1 |
-9,612
|
-17,73
|
-17,86
|
-19,72
|
-6,821
|
-12,11
|
-14,45
|
-18,32
|
-11,61
|
-23,89
|
Nettomarge
|
-40,25%
|
-50,94%
|
-813,25%
|
-689,58%
|
-31,81%
|
-143,3%
|
-144,14%
|
-186,8%
|
-131,48%
|
-289,28%
|
WPA
2 |
-0,1500
|
-0,2800
|
-0,2800
|
-0,2400
|
-0,0800
|
-0,1400
|
-0,1600
|
-0,1900
|
-0,1200
|
-0,2400
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13/05/21
|
16/08/21
|
15/11/21
|
30/03/22
|
12/05/22
|
11/08/22
|
10/11/22
|
20/03/23
|
11/05/23
|
14/08/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
286
|
198
|
177
|
108
|
7,2
|
12,9
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
4,314
x
|
2,559
x
|
3,28
x
|
5,156
x
|
-0,1042
x
|
-0,3269
x
|
Free Cash Flow
1 |
32,8
|
43,9
|
36,3
|
15,1
|
-23,4
|
-12,7
|
ROE (netto-inkomsten/eigen vermogen)
|
-10,5%
|
-26,6%
|
-109%
|
-76,3%
|
-97,1%
|
-80,9%
|
ROA (netto-inkomsten/totale activa)
|
2,09%
|
0,41%
|
0,3%
|
0,26%
|
-18,7%
|
-18,3%
|
Totale activa
1 |
-2.166
|
-26.418
|
-89.406
|
-30.412
|
346,4
|
282,6
|
Nettoactief per aandeel
2 |
405,0
|
7,350
|
2,210
|
1,500
|
0,9200
|
0,5200
|
Cashflow per aandeel
2 |
34,70
|
1,350
|
1,850
|
1,820
|
0,4900
|
0,4500
|
Capex
1 |
19,4
|
4,14
|
3,96
|
2,92
|
1,78
|
0,75
|
Capex/omzet
|
7,89%
|
1,57%
|
1,65%
|
1,64%
|
10,18%
|
1,51%
|
Datum van publicatie
|
9/05/18
|
28/03/19
|
19/03/20
|
30/03/21
|
30/03/22
|
20/03/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| 0,00% | 111 | | -4,66% | 86,13 mld. | | +1,32% | 39,82 mld. | | -19,27% | 30,42 mld. | | +57,86% | 25,23 mld. | | -16,09% | 15,36 mld. | | -9,14% | 11,95 mld. | | -17,69% | 11,6 mld. | | -43,00% | 11,51 mld. | | +5,24% | 8,71 mld. |
Biofarmaceutica
|